GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sinclair Pharma PLC (XPAR:SPH) » Definitions » Investments And Advances

Sinclair Pharma (XPAR:SPH) Investments And Advances : €0.00 Mil (As of Jun. 2018)


View and export this data going back to . Start your Free Trial

What is Sinclair Pharma Investments And Advances?

Sinclair Pharma's Investments And Advances for the quarter that ended in Jun. 2018 was €0.00 Mil.


Sinclair Pharma Investments And Advances Historical Data

The historical data trend for Sinclair Pharma's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinclair Pharma Investments And Advances Chart

Sinclair Pharma Annual Data
Trend Jun07 Jun08 Jun09 Jun10 Jun11 Jun12 Jun13 Jun14 Jun15 Dec17
Investments And Advances
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Sinclair Pharma Semi-Annual Data
Jun08 Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Jun17 Dec17 Jun18
Investments And Advances Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Sinclair Pharma Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.


Sinclair Pharma (XPAR:SPH) Business Description

Traded in Other Exchanges
N/A
Address
Sinclair Pharma PLC is a United Kingdom-based specialty pharmaceutical company focused on Dermatology, in particular, Aesthetics, Wound care, and Skin care. The group has a direct sales and marketing presence in the top five European markets and a rapidly growing International division concentrated on key emerging markets through long-term multi-product, multi-country, sales & marketing and distribution deals with key strategic partners. The Company's reportable operating segments are International Operations, France, Italy, Germany, UK, and Spain.